Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease.

[1]  R. D'Agostino.  Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .

[2]  K. Adams,et al.  In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, Journal of the American College of Cardiology.

[3]  W John Boscardin,et al.  Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. , 2005, JAMA.

[4]  K. Adams,et al.  Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.

[5]  D. McGill,et al.  Acute Myocardial Infarction Associated with Albuterol , 2004, The Annals of pharmacotherapy.

[6]  D. Au,et al.  Association between chronic heart failure and inhaled β-2-adrenoceptor agonists , 2004 .

[7]  E. Salpeter,et al.  Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. , 2004, Chest.

[8]  J. Walters,et al.  Adverse Effects of β-Agonists , 2003 .

[9]  L. McCaig,et al.  National Hospital Ambulatory Medical Care Survey: 2001 emergency department summary. , 2003, Advance data.

[10]  J. Curtis,et al.  Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction. , 2003, Chest.

[11]  O. Obeidat,et al.  Asthma, beta-agonists, and development of congestive heart failure: results of the ABCHF study. , 2002, Journal of cardiac failure.

[12]  B. Psaty,et al.  The Risk of Myocardial Infarction Associated with Inhaled β -Adrenoceptor Agonists , 2000 .

[13]  B. Gersh,et al.  Respiratory illness, beta-agonists, and risk of idiopathic dilated cardiomyopathy. The Washington, DC, Dilated Cardiomyopathy Study. , 1995, American journal of epidemiology.

[14]  A. Oliven,et al.  Cardiac arrhythmias after inhaled bronchodilators in patients with COPD and ischemic heart disease. , 1993, Chest.

[15]  D. Rubin,et al.  Reducing Bias in Observational Studies Using Subclassification on the Propensity Score , 1984 .

[16]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[17]  M. Cazzola,et al.  Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. , 2005, Drugs.